Chemotherapy regimens for advanced pancreatic cancer: A systematic review and network meta-analysis

Advanced pancreatic cancer confers poor prognosis and treatment advancement has been slow. Recent randomized clinical trials (RCTs) have demonstrated survival benefits for combination therapy compared to gemcitabine alone.